Daraprim

US FDA to check Martin Shkreli's type of strategies to spiraling up drug prices

With an objective of not giving any such scope for price escalation as Martin Shkreli did for Daraprim generic drug, US Food and Drug Administration (US FDA) has turned very cautious on approvals to generic drugs. US FDA is now reviewing new applications for generic drugs, while ensuring no such lapses of price escalation.

Read Full Article

Express Scripts offers cheaper $1 pill alternative to Turing's $750 per pill drug

Drug prescription firm Express Scripts Holding Co. found a way to offer a cheaper $1 alternative to Turing’s $750 a pill drug.

Read Full Article

Turing Pharmaceuticals Won't Cut Price of Daraprim

Turing Pharmaceuticals said that it won't cut the list price of the drug. However, it will negotiate discount price with hospital. Last September, Turing Pharmaceuticals raised the price of live-saving drugs, Daraprim by more than fifty times.

Read Full Article

Daraprim price hike could affect the pharmaceutical industry

The overnight price hiked of Daraprim drug by the start-up, Turing Pharmaceutical is creating a big impact to the pharmaceutical sectors worldwide. The company which is own by a former hedge fund manager had acquired the right of the drug in August and immediately increases its price. The move is causing a backlash to pharmaceutical industry creating most of the shares down in a massive sell-off.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics